RedHill Biopharma Ltd.
RDHL
$1.02
-$0.01-0.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -2.07M | -2.07M | -2.59M |
| Total Depreciation and Amortization | -- | -- | 84.00K | 84.00K | 100.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -214.00K | -214.00K | 1.25M |
| Change in Net Operating Assets | -- | -- | -311.00K | -311.00K | 79.50K |
| Cash from Operations | -- | -- | -2.51M | -2.51M | -1.16M |
| Capital Expenditure | -- | -- | -2.00K | -2.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -2.00K | -2.00K | -4.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -94.50K | -94.50K | -111.00K |
| Issuance of Common Stock | -- | -- | 1.72M | 1.72M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -104.50K |
| Cash from Financing | -- | -- | 1.63M | 1.63M | -215.50K |
| Foreign Exchange rate Adjustments | -- | -- | 4.50K | 4.50K | 7.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -875.50K | -875.50K | -1.37M |